Etoposide Capsule
Product Images NDC 0378-3266

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etoposide (NDC 0378-3266). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Etoposide Structural Formula (E8afb8ba 1f76 47f4 985f D785d5e66212 01)

Chemical structure diagram illustrating the molecular structure of etoposide, the active ingredient in Etoposide 50 mg capsules by Mylan Pharmaceuticals Inc.*

FDA Label Image

Etoposide Capsules, Usp 50 mg Carton Label (Image 01)

Packaging label for Etoposide 50 mg capsules, USP, by Mylan Pharmaceuticals Inc. This unit dose package contains 20 capsules in 2 blister strips of 10 capsules each. The label includes NDC 0378-3266-94, storage instructions (refrigerate at 2° to 8°C), and a QR code and barcode for product identification.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.